Metraipolis › archive › dc_7c9cd35f0d15
Patient-reported outcomes from the randomized ALICE trial evaluating the addition of atezolizumab to anthracycline-based chemotherapy in metastatic… — Europe PMC PMID:41581361
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41581361
- DOI
- 10.1016/j.breast.2026.104704
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T17:19:54.942Z
- SHA-256 of the archived text
91d7096f3647e1c12fd600f51f933de2ead75f6aaa3e0210913cca3c405f47cb- Stable URL of this page
https://metraipolis.com/documento/dc_7c9cd35f0d15
How to cite
Patient-reported outcomes from the randomized ALICE trial evaluating the addition of atezolizumab to anthracycline-based chemotherapy in metastatic… — Europe PMC PMID:41581361 — Europe PMC (en), https://europepmc.org/article/MED/41581361 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7c9cd35f0d15 (Metraipolis archive dc_7c9cd35f0d15, sha256 91d7096f3647e1c12fd600f51f933de2ead75f6aaa3e0210913cca3c405f47cb)
BibTeX
@misc{dc7c9cd35f0d15,
title = {Patient-reported outcomes from the randomized ALICE trial evaluating the addition of atezolizumab to anthracycline-based chemotherapy in metastatic… — Europe PMC PMID:41581361},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41581361},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7c9cd35f0d15; sha256 91d7096f3647e1c12fd600f51f933de2ead75f6aaa3e0210913cca3c405f47cb},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41581361. Agents can read the archived copy with the MCP tool read_document.